颈动脉粥样硬化生物标志物在心血管疾病预防中的应用:系统综述与文献计量分析
该研究对1997至2018年颈动脉粥样硬化文献进行系统综述与文献计量分析,纳入31793篇文献和407473条被引参考文献,通过共词网络和共被引网络分析发现该领域分为三个社区:心血管疾病一级预防、二级预防和影像技术表征颈动脉粥样硬化。结论指出颈动脉粥样硬化生物标志物演化阶段差异大,联合评估斑块影像特征可能有助于改善心血管疾病预防的风险预测和临床决策。
要点
- 颈动脉粥样硬化生物标志物研究可归为心血管疾病一级预防、二级预防和影像技术表征三个主要方向。
- 颈动脉粥样硬化生物标志物的演化通常经历概念化、验证和再分类三个阶段。
- 联合评估包含不同颈动脉斑块特征的测量指标,而非单独使用某一指标,对心血管风险或临床决策可能更有价值。
核心结论
- 颈动脉粥样硬化生物标志物的演化阶段存在广泛差异,但联合评估颈动脉斑块影像特征可能有助于改善心血管疾病预防的风险预测和临床决策。
研究设计与样本
- 研究类型为系统综述与文献计量分析,采用综合检索策略构建1997至2018年颈动脉粥样硬化文献的代表性数据集。
- 共纳入31793篇检索文献和407473条被引参考文献,通过共词网络和共被引网络描述主要学科和主题。
- 通过突发分析检测里程碑文献,以描绘颈动脉粥样硬化生物标志物研究的演化模式和新兴趋势。
关键影像表现/征象
- 颈动脉粥样硬化是一个多学科研究领域,可分为三个社区:心血管疾病一级预防、心血管疾病二级预防和表征颈动脉粥样硬化的影像技术。
诊断标准与关键数值
- 颈动脉粥样硬化生物标志物的演化可能经历三个阶段:概念化阶段、验证阶段和再分类阶段。
- 包含不同颈动脉斑块特征的测量指标联合应用,而非单独使用,已显示出对心血管风险或临床决策的更大价值。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: While carotid atherosclerosis (CA) biomarkers are valuable surrogates for cardiovascular events, their inadequate utility is highlighted by clinical practice. We performed an interdisciplinary systematic review and bibliometric analysis to identify the knowledge gaps and offer directions for future research.
METHODS: We applied a comprehensive search strategy to construct a representative dataset of the bibliographic records of CA from 1997 to 2018. A total of 31,793 retrieved articles and 407,473 cited references were included in the analysis. The co-word network and co-citation network were derived to describe the major disciplines and topics of CA research. Milestones detected by burst analysis were reviewed to delineate the evolutionary patterns and emerging trends of research on CA biomarkers.
RESULTS: CA is a multidisciplinary field of study which could be divided into 3 communities: the primary prevention of CVD, the secondary prevention of CVD and imaging techniques to characterize carotid atherosclerosis. The evolution of a CA biomarker may go through 3 stages: the conceptualization stage, the validation stage and the reclassification stage. Measurements that include different CA plaque features, rather than separately, have shown greater value for cardiovascular risk or clinical decision-making.
CONCLUSIONS: Although wide variability exists in the evolutionary stages of CA biomarkers, combined evaluation of CA plaque imaging features shows potential value to improve risk prediction and clinical decision-making for CVD prevention.
引用
- Fu Q, Wang X, Wu T, et al. Carotid atherosclerosis biomarkers in cardiovascular diseases prevention: A systematic review and bibliometric analysis. Eur J Radiol. 2020. PMID: 32610187. doi:10.1016/j.ejrad.2020.109133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。